Szabolcs I, Ploenes C, Beyer M, Bernard W, Herrmann J
1st Department of Medicine, Postgraduate Medical University, Budapest, Hungary.
J Am Geriatr Soc. 1993 Jul;41(7):742-6. doi: 10.1111/j.1532-5415.1993.tb07464.x.
Determination of whether nonthyroidal factors affect the diagnostic value of free thyroxine estimation in geriatric patients.
Survey.
A convenience sample of 381 non-selected, chronic, hospitalized geriatric patients over 60 years of age (I = relatively good health; II = relatively poor health; III = bad health; subgroups "sine therapia," ie, patients receiving no drugs that affect FT4) and 180 20-40 year old healthy persons.
Thyrotropin-releasing hormone test; thyrotropin (TSH); free thyroxine (FT4, measured in part by two parallel methods) estimation in a screening study; and thyroxine-binding globulin and thyroxine-binding-inhibitor activity measurements.
The normal FT4 ranges of the euthyroid geriatric (n = 210) and healthy young groups were similar. In the "sine therapia" euthyroid patients, FT4 decreased with age but increase with the severity of illness. High FT4 levels with non-suppressed TSH were more frequent in patients in poor and bad health. (I = 6/112; II = 14/140; III = 13/74; P < 0.01). The serum thyroxine-binding-inhibitor activity of euthyroid geriatric patients correlated with the severity of their clinical state (I = 6.22 +/- 5.65 (13); II = 7.40 +/- 4.33 (23); III = 10.04 +/- 5.50 (16) micrograms merthiolate equivalent/microL; ANOVA with log-transformed values: F(2.51) = 3.50, P < 0.05). The mean FT4 was higher in 36 heparin-treated patients (22.81 +/- 4.67 pmol/L) than in the 193 "sine therapia" patients (19.03 +/- 4.23 pmol/L; -P < 0.001). In a convenience subsample of 240 patients, a weak inverse correlation was found between FT4 and the thyroxine-binding globulin (r = -0.14, P < 0.02). Only 5/11 patients with low free thyroxine had hypothyroidism, while 11/46 patients with elevated free thyroxine had hyperthyroidism.
There is no need to modify the normal free thyroxine range for hospitalized geriatric patients. Clinical condition, drug treatment, and, to a lesser extent, age are factors that significantly affect the diagnostic value of FT4 in hospitalized chronic geriatric patients, decreasing the specificity of the test in diagnosing clinical hyper- and hypothyroidism.
确定非甲状腺因素是否会影响老年患者游离甲状腺素测定的诊断价值。
调查。
选取381例60岁以上未经过挑选的慢性住院老年患者(I = 健康状况相对良好;II = 健康状况相对较差;III = 健康状况差;亚组“无治疗”,即未接受影响FT4的药物治疗的患者)作为便利样本,以及180名20 - 40岁的健康人。
促甲状腺激素释放激素试验;促甲状腺激素(TSH);在一项筛查研究中进行游离甲状腺素(FT4,部分通过两种平行方法测量)测定;以及甲状腺素结合球蛋白和甲状腺素结合抑制活性测量。
甲状腺功能正常的老年患者(n = 210)和健康年轻组的正常FT4范围相似。在“无治疗”的甲状腺功能正常患者中,FT4随年龄降低,但随疾病严重程度增加。甲状腺功能正常但TSH未被抑制的高FT4水平在健康状况差和极差的患者中更常见。(I = 6/112;II = 14/140;III = 13/74;P < 0.01)。甲状腺功能正常的老年患者的血清甲状腺素结合抑制活性与其临床状态的严重程度相关(I = 6.22 ± 5.65(13);II = 7.40 ± 4.33(23);III = 10.04 ± 5.50(16)微克硫柳汞当量/微升;对数值进行方差分析:F(2.51) = 3.50,P < 0.05)。36例接受肝素治疗的患者的平均FT4(22.81 ± 4.67 pmol/L)高于193例“无治疗”患者(19.03 ± 4.23 pmol/L;P < 0.001)。在240例患者的便利子样本中,发现FT4与甲状腺素结合球蛋白之间存在弱负相关(r = -0.14,P < 0.02)。游离甲状腺素低的11例患者中只有5例患有甲状腺功能减退,而游离甲状腺素升高的46例患者中有11例患有甲状腺功能亢进。
无需修改住院老年患者的正常游离甲状腺素范围。临床状况、药物治疗以及在较小程度上年龄是显著影响住院慢性老年患者FT4诊断价值的因素,降低了该检测在诊断临床甲状腺功能亢进和减退中的特异性。